Amazon.com, Inc. (AMZN)

Latest news, insights and market data

Market Data

$238.38
$4.73 (+2.02%)
Previous Close: $233.65
52-Week Range
95% from low
$196.00$240.43

AI Insights

Amazon Pharmacy is now offering Eli Lilly's new weight loss medication, Foundayo, with same-day delivery, intensifying competition in the growing obesity treatment market. This move could reshape how consumers access weight-loss drugs and positions Amazon as a significant player in the healthcare space. The implications for market dynamics and consumer choices are noteworthy.

Updated 29 minutes ago

Latest News

Hims And Hers Confronts Amazon Threat While Advancing AI Weight Loss Plan

Amazon Pharmacy has entered the weight loss medication market with Eli Lilly’s new GLP-1 drug, offering same day delivery and raising competitive pressure on Hims & Hers Health (NYSE:HIMS). Hims & Hers is developing an AI driven product approach that may support new non prescription solutions and product rollouts later this year. The company is also contending with regulatory scrutiny and margin pressures as its weight loss offerings become a more important part of its business mix. Hims &...

about 4 hours ago

Why Amazon Is Not The AI Chip Provider Broadcom Is

Amazon CEO Jassy touts bullish AI chip growth and $200B capex clarity.

about 5 hours ago

Your Lifetime Earnings Are Tracked On The Social Security Website. Here's Why Some People Compare It To Their Net Worth. 'Oh This Is Fun'

Your Lifetime Earnings Are Tracked On The Social Security Website. Here's Why Some People Compare It To Their Net Worth. 'Oh This Is Fun'

about 8 hours ago

Your Lifetime Earnings Are Tracked On The Social Security Website. Here's Why Some People Compare It To Their Net Worth. 'Oh This Is Fun'

For many people focused on financial independence, the usual milestones are: hitting a certain net worth, covering expenses with investment income, or reaching the well-known “25x annual expenses” rule. But a quieter metric has started getting attention online–comparing your lifetime...

about 8 hours ago

Wall Street Banks Try Out Anthropic’s Mythos as US Urges

Wall Street Banks Try Out Anthropic’s Mythos as US Urges

about 9 hours ago

Wall Street Banks Try Out Anthropic’s Mythos as US Urges

(Bloomberg) -- Wall Street banks are starting to test Anthropic PBC’s Mythos model internally as Trump administration officials encourage them to use it to detect vulnerabilities.While JPMorgan Chase & Co. was the only bank named as part of an initiative to test the Mythos model, other major financial institutions have also gained access or expect to in the coming days, according to people familiar with the matter. Goldman Sachs Group Inc., Citigroup Inc., Bank of America Corp. and Morgan Stanle

about 9 hours ago

Amazon (AMZN) Increases Despite Market Slip: Here's What You Need to Know

Amazon (AMZN) Increases Despite Market Slip: Here's What You Need to Know

about 9 hours ago